Dirk Arnold
Impact in
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- PARP inhibition in cancer therapy
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Cancer Immunotherapy and Biomarkers
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 81
- Colorectal Cancer Treatments and Studies 43
- Pancreatic and Hepatic Oncology Research 16
- PARP inhibition in cancer therapy 13
- Colorectal Cancer Surgical Treatments 11
-
- Gastric Cancer Management and Outcomes 21
- Co-authors
- Daniel Hochhauser (17 shared papers)Eric Van Cutsem (30 shared papers)Anke Reinacher‐Schick (15 shared papers)Hedy L. Kindler (16 shared papers)David McGuinness (16 shared papers)Michele Reni (16 shared papers)Talia Golan (16 shared papers)Teresa Macarulla (13 shared papers)
In The Last Decade
Dirk Arnold
95 papers receiving 4.1k citations
Dirk Arnold's Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 2.9k
- Hepatology 614
- Cancer Research 1.1k
- Pathology and Forensic Medicine 602
- Pulmonary and Respiratory Medicine 921
Countries citing papers authored by Dirk Arnold
This map shows the geographic impact of Dirk Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Arnold more than expected).
Fields of papers citing papers by Dirk Arnold
This network shows the impact of papers produced by Dirk Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Arnold. The network helps show where Dirk Arnold may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Arnold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer Hit paper breakdown → | 2019 | 1468 |
| 2 | Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2020 | 736 |
| 3 | Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2018 | 712 |
| 4 | 2020 | 164 | |
| 5 | 2019 | 161 | |
| 6 | 2022 | 120 | |
| 7 | 2018 | 85 | |
| 8 | 2018 | 75 | |
| 9 | 2021 | 59 | |
| 10 | 2018 | 50 | |
| 11 | 2020 | 49 | |
| 12 | 2019 | 33 | |
| 13 | 2018 | 33 | |
| 14 | Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2025 | 21 |
| 15 | 2010 | 19 | |
| 16 | 2023 | 18 | |
| 17 | 2018 | 18 | |
| 18 | 2021 | 16 | |
| 19 | 2018 | 16 | |
| 20 | 2022 | 16 |
About Dirk Arnold
Dirk Arnold is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Hepatology, having authored 108 papers that have together received 4.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (43 papers), Gastric Cancer Management and Outcomes (21 papers), Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), PARP inhibition in cancer therapy (13 papers), Economic and Financial Impacts of Cancer (11 papers) and Colorectal Cancer Surgical Treatments (11 papers). The work is most often cited by research in Oncology (2.9k citations), Hepatology (614 citations), Cancer Research (1.1k citations), Pathology and Forensic Medicine (602 citations) and Pulmonary and Respiratory Medicine (921 citations). Dirk Arnold has collaborated with scholars based in Germany, France and Spain. Frequent co-authors include Daniel Hochhauser, Eric Van Cutsem, Anke Reinacher‐Schick, Hedy L. Kindler, David McGuinness, Michele Reni, Talia Golan, Teresa Macarulla, Pascal Hammel and Giampaolo Tortora. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Clinical Colorectal Cancer, ESMO Open and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.